TargetATP-dependent 6-phosphofructokinase, muscle type(Homo sapiens (Human))
Metabasis Therapeutics
Curated by ChEMBL
Metabasis Therapeutics
Curated by ChEMBL
Affinity DataEC50: >1.00E+5nMAssay Description:Inhibition of phosphofructokinase AMP binding siteMore data for this Ligand-Target Pair